Index by author
September 01, 2017; Volume 362,Issue 3
A
Abraham, Pamela
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
Amano, Nobuyuki
- You have accessMechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese MiceShinji Iwasaki, Teruki Hamada, Ikumi Chisaki, Tomohiro Andou, Noriyasu Sano, Atsutoshi Furuta and Nobuyuki AmanoJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 441-449; DOI: https://doi.org/10.1124/jpet.117.242651
Andersen, Julie K
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Andou, Tomohiro
- You have accessMechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese MiceShinji Iwasaki, Teruki Hamada, Ikumi Chisaki, Tomohiro Andou, Noriyasu Sano, Atsutoshi Furuta and Nobuyuki AmanoJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 441-449; DOI: https://doi.org/10.1124/jpet.117.242651
B
Bailey, Isaac R.
- You have accessOptimization of Thermolytic Response to A1 Adenosine Receptor Agonists in RatsIsaac R. Bailey, Bernard Laughlin, Lucille A. Moore, Lori K. Bogren, Zeinab Barati and Kelly L. DrewJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 424-430; DOI: https://doi.org/10.1124/jpet.117.241315
Barati, Zeinab
- You have accessOptimization of Thermolytic Response to A1 Adenosine Receptor Agonists in RatsIsaac R. Bailey, Bernard Laughlin, Lucille A. Moore, Lori K. Bogren, Zeinab Barati and Kelly L. DrewJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 424-430; DOI: https://doi.org/10.1124/jpet.117.241315
Bogren, Lori K.
- You have accessOptimization of Thermolytic Response to A1 Adenosine Receptor Agonists in RatsIsaac R. Bailey, Bernard Laughlin, Lucille A. Moore, Lori K. Bogren, Zeinab Barati and Kelly L. DrewJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 424-430; DOI: https://doi.org/10.1124/jpet.117.241315
Bohrmann, Bernd
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Borroni, Edilio
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Boss, Christoph
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
Breier, Anna B.
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
Burckhardt, Birgitta C.
- You have accessDifferential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3Birgitta C. Burckhardt, Maja Henjakovic, Yohannes Hagos and Gerhard BurckhardtJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 450-458; DOI: https://doi.org/10.1124/jpet.117.241406
Burckhardt, Gerhard
- You have accessDifferential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3Birgitta C. Burckhardt, Maja Henjakovic, Yohannes Hagos and Gerhard BurckhardtJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 450-458; DOI: https://doi.org/10.1124/jpet.117.241406
C
Callan, Sean Patrick
- You have accessMolecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for TreatmentAnna Moszczynska and Sean Patrick CallanJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 474-488; DOI: https://doi.org/10.1124/jpet.116.238501
Cesura, Andrea M
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Chen, Shenjue
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
Chen, Weiqi
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
Cheng, Yaofeng
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
Chinta, Shankar J
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Chisaki, Ikumi
- You have accessMechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese MiceShinji Iwasaki, Teruki Hamada, Ikumi Chisaki, Tomohiro Andou, Noriyasu Sano, Atsutoshi Furuta and Nobuyuki AmanoJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 441-449; DOI: https://doi.org/10.1124/jpet.117.242651
Court, Michael H.
- You have accessRace, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American VolunteersMichael H. Court, Zhaohui Zhu, Gina Masse, Su X. Duan, Laura P. James, Jerold S. Harmatz and David J. GreenblattJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 431-440; DOI: https://doi.org/10.1124/jpet.117.242107
D
de Guglielmo, Giordano
- You have accessCebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in RatsGiordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, Julia Mattioni, Rémi Martin-Fardon and Olivier GeorgeJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 378-384; DOI: https://doi.org/10.1124/jpet.117.241042
de Kanter, Ruben
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
Dillon, Glenn H.
- You have accessA Single Amino Acid Residue at Transmembrane Domain 4 of the α Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA ReceptorsManoj Kumar, Manish Kumar, John M. Freund and Glenn H. DillonJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 395-404; DOI: https://doi.org/10.1124/jpet.117.242156
Drew, Kelly L.
- You have accessOptimization of Thermolytic Response to A1 Adenosine Receptor Agonists in RatsIsaac R. Bailey, Bernard Laughlin, Lucille A. Moore, Lori K. Bogren, Zeinab Barati and Kelly L. DrewJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 424-430; DOI: https://doi.org/10.1124/jpet.117.241315
Duan, Su X.
- You have accessRace, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American VolunteersMichael H. Court, Zhaohui Zhu, Gina Masse, Su X. Duan, Laura P. James, Jerold S. Harmatz and David J. GreenblattJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 431-440; DOI: https://doi.org/10.1124/jpet.117.242107
E
Ellenbroek, Bart
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
F
Fowler, Daniel K.
- You have accessEthyl Vanillin Activates TRPA1Shaw-wen Wu, Daniel K. Fowler, Forrest J. Shaffer, Jonathon E. M. Lindberg and James H. PetersJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 368-377; DOI: https://doi.org/10.1124/jpet.116.239384
Freeden, Chris
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
Freund, John M.
- You have accessA Single Amino Acid Residue at Transmembrane Domain 4 of the α Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA ReceptorsManoj Kumar, Manish Kumar, John M. Freund and Glenn H. DillonJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 395-404; DOI: https://doi.org/10.1124/jpet.117.242156
Furuta, Atsutoshi
- You have accessMechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese MiceShinji Iwasaki, Teruki Hamada, Ikumi Chisaki, Tomohiro Andou, Noriyasu Sano, Atsutoshi Furuta and Nobuyuki AmanoJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 441-449; DOI: https://doi.org/10.1124/jpet.117.242651
G
Gan, Jinping
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
Ganey, Patricia E.
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
Gatfield, John
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
George, Olivier
- You have accessCebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in RatsGiordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, Julia Mattioni, Rémi Martin-Fardon and Olivier GeorgeJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 378-384; DOI: https://doi.org/10.1124/jpet.117.241042
Greenblatt, David J.
- You have accessRace, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American VolunteersMichael H. Court, Zhaohui Zhu, Gina Masse, Su X. Duan, Laura P. James, Jerold S. Harmatz and David J. GreenblattJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 431-440; DOI: https://doi.org/10.1124/jpet.117.242107
Grueninger, Fiona
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
H
Hagos, Yohannes
- You have accessDifferential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3Birgitta C. Burckhardt, Maja Henjakovic, Yohannes Hagos and Gerhard BurckhardtJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 450-458; DOI: https://doi.org/10.1124/jpet.117.241406
Hamada, Teruki
- You have accessMechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese MiceShinji Iwasaki, Teruki Hamada, Ikumi Chisaki, Tomohiro Andou, Noriyasu Sano, Atsutoshi Furuta and Nobuyuki AmanoJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 441-449; DOI: https://doi.org/10.1124/jpet.117.242651
Harmatz, Jerold S.
- You have accessRace, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American VolunteersMichael H. Court, Zhaohui Zhu, Gina Masse, Su X. Duan, Laura P. James, Jerold S. Harmatz and David J. GreenblattJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 431-440; DOI: https://doi.org/10.1124/jpet.117.242107
Henjakovic, Maja
- You have accessDifferential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3Birgitta C. Burckhardt, Maja Henjakovic, Yohannes Hagos and Gerhard BurckhardtJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 450-458; DOI: https://doi.org/10.1124/jpet.117.241406
Hession, Sarah L.
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
Humphreys, W. Griffith
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
I
Iwasaki, Shinji
- You have accessMechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese MiceShinji Iwasaki, Teruki Hamada, Ikumi Chisaki, Tomohiro Andou, Noriyasu Sano, Atsutoshi Furuta and Nobuyuki AmanoJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 441-449; DOI: https://doi.org/10.1124/jpet.117.242651
J
James, Laura P.
- You have accessRace, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American VolunteersMichael H. Court, Zhaohui Zhu, Gina Masse, Su X. Duan, Laura P. James, Jerold S. Harmatz and David J. GreenblattJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 431-440; DOI: https://doi.org/10.1124/jpet.117.242107
Jenck, Francois
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
K
Kaur, Gurpreet
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
Kononoff, Jenni
- You have accessCebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in RatsGiordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, Julia Mattioni, Rémi Martin-Fardon and Olivier GeorgeJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 378-384; DOI: https://doi.org/10.1124/jpet.117.241042
Kumar, Manish
- You have accessA Single Amino Acid Residue at Transmembrane Domain 4 of the α Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA ReceptorsManoj Kumar, Manish Kumar, John M. Freund and Glenn H. DillonJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 395-404; DOI: https://doi.org/10.1124/jpet.117.242156
Kumar, Manoj
- You have accessA Single Amino Acid Residue at Transmembrane Domain 4 of the α Subunit Influences Carisoprodol Direct Gating Efficacy at GABAA ReceptorsManoj Kumar, Manish Kumar, John M. Freund and Glenn H. DillonJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 395-404; DOI: https://doi.org/10.1124/jpet.117.242156
L
Lai, Yurong
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
Lansdell, Theresa
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
Laughlin, Bernard
- You have accessOptimization of Thermolytic Response to A1 Adenosine Receptor Agonists in RatsIsaac R. Bailey, Bernard Laughlin, Lucille A. Moore, Lori K. Bogren, Zeinab Barati and Kelly L. DrewJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 424-430; DOI: https://doi.org/10.1124/jpet.117.241315
Lindberg, Jonathon E. M.
- You have accessEthyl Vanillin Activates TRPA1Shaw-wen Wu, Daniel K. Fowler, Forrest J. Shaffer, Jonathon E. M. Lindberg and James H. PetersJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 368-377; DOI: https://doi.org/10.1124/jpet.116.239384
Loetscher, Hansruedi
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
M
Maiuri, Ashley R.
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
Martin-Fardon, Rémi
- You have accessCebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in RatsGiordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, Julia Mattioni, Rémi Martin-Fardon and Olivier GeorgeJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 378-384; DOI: https://doi.org/10.1124/jpet.117.241042
Masse, Gina
- You have accessRace, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American VolunteersMichael H. Court, Zhaohui Zhu, Gina Masse, Su X. Duan, Laura P. James, Jerold S. Harmatz and David J. GreenblattJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 431-440; DOI: https://doi.org/10.1124/jpet.117.242107
Mattioni, Julia
- You have accessCebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in RatsGiordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, Julia Mattioni, Rémi Martin-Fardon and Olivier GeorgeJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 378-384; DOI: https://doi.org/10.1124/jpet.117.241042
Matzeu, Alessandra
- You have accessCebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in RatsGiordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, Julia Mattioni, Rémi Martin-Fardon and Olivier GeorgeJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 378-384; DOI: https://doi.org/10.1124/jpet.117.241042
Messer, Juerg
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Moore, Lucille A.
- You have accessOptimization of Thermolytic Response to A1 Adenosine Receptor Agonists in RatsIsaac R. Bailey, Bernard Laughlin, Lucille A. Moore, Lori K. Bogren, Zeinab Barati and Kelly L. DrewJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 424-430; DOI: https://doi.org/10.1124/jpet.117.241315
Moszczynska, Anna
- You have accessMolecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for TreatmentAnna Moszczynska and Sean Patrick CallanJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 474-488; DOI: https://doi.org/10.1124/jpet.116.238501
Muehlan, Clemens
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
N
Nave, Stephane
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Nelson, David M.
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
P
Pähler, Axel
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Peters, James H.
- You have accessEthyl Vanillin Activates TRPA1Shaw-wen Wu, Daniel K. Fowler, Forrest J. Shaffer, Jonathon E. M. Lindberg and James H. PetersJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 368-377; DOI: https://doi.org/10.1124/jpet.116.239384
Prinssen, Eric
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
R
Rajagopalan, Subramanian
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Rane, Anand
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Roch, Catherine
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
Roth, Robert A.
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
S
Sandoval, Philip J.
- You have accessCorrelation between Apparent Substrate Affinity and OCT2 Transport TurnoverAlyscia Cory Severance, Philip J. Sandoval and Stephen H. WrightJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 405-412; DOI: https://doi.org/10.1124/jpet.117.242552
Sano, Noriyasu
- You have accessMechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese MiceShinji Iwasaki, Teruki Hamada, Ikumi Chisaki, Tomohiro Andou, Noriyasu Sano, Atsutoshi Furuta and Nobuyuki AmanoJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 441-449; DOI: https://doi.org/10.1124/jpet.117.242651
Schindelholz, Benno
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
Severance, Alyscia Cory
- You have accessCorrelation between Apparent Substrate Affinity and OCT2 Transport TurnoverAlyscia Cory Severance, Philip J. Sandoval and Stephen H. WrightJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 405-412; DOI: https://doi.org/10.1124/jpet.117.242552
Shaffer, Forrest J.
- You have accessEthyl Vanillin Activates TRPA1Shaw-wen Wu, Daniel K. Fowler, Forrest J. Shaffer, Jonathon E. M. Lindberg and James H. PetersJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 368-377; DOI: https://doi.org/10.1124/jpet.116.239384
Siddiqui, Almas
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
T
Treiber, Alexander
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
Turkus, Jonathan D.
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
V
van Gerven, Joop
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
von Raumer, Markus
- You have accessThe Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven and Francois JenckJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 489-503; DOI: https://doi.org/10.1124/jpet.117.241596
W
Wassink, Bronlyn
- You have accessSynergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept StudyAshley R. Maiuri, Bronlyn Wassink, Jonathan D. Turkus, Anna B. Breier, Theresa Lansdell, Gurpreet Kaur, Sarah L. Hession, Patricia E. Ganey and Robert A. RothJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 459-473; DOI: https://doi.org/10.1124/jpet.117.242354
Wright, Stephen H.
- You have accessCorrelation between Apparent Substrate Affinity and OCT2 Transport TurnoverAlyscia Cory Severance, Philip J. Sandoval and Stephen H. WrightJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 405-412; DOI: https://doi.org/10.1124/jpet.117.242552
Wu, Shaw-wen
- You have accessEthyl Vanillin Activates TRPA1Shaw-wen Wu, Daniel K. Fowler, Forrest J. Shaffer, Jonathon E. M. Lindberg and James H. PetersJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 368-377; DOI: https://doi.org/10.1124/jpet.116.239384
Wyler, Rene
- Open AccessSembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s DiseaseEdilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Nave, Hansruedi Loetscher, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K Andersen, Rene Wyler and Andrea M CesuraJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 413-423; DOI: https://doi.org/10.1124/jpet.117.241653
Z
Zhang, Yueping
- You have accessBile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of TroglitazoneYaofeng Cheng, Shenjue Chen, Chris Freeden, Weiqi Chen, Yueping Zhang, Pamela Abraham, David M. Nelson, W. Griffith Humphreys, Jinping Gan and Yurong LaiJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 385-394; DOI: https://doi.org/10.1124/jpet.117.242370
Zhu, Zhaohui
- You have accessRace, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American VolunteersMichael H. Court, Zhaohui Zhu, Gina Masse, Su X. Duan, Laura P. James, Jerold S. Harmatz and David J. GreenblattJournal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 431-440; DOI: https://doi.org/10.1124/jpet.117.242107
In this issue
Advertisement